AF

Alexandre Fraichard

Chief Executive Officer

genOway

Lyon, Auvergne-Rhone-Alpes


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
genOway
Industry
research
Employees
130.0
Seniority
C suite
Annual Revenue
10591000.0

Technologies

Outlook Microsoft Office 365 Amazon AWS Amplitude Webflow Hubspot Google Dynamic Remarketing Mobile Friendly YouTube Google Tag Manager Linkedin Login DoubleClick Nginx Google Font API DoubleClick Conversion Hotjar reCAPTCHA Linkedin Widget Vimeo WordPress.org LiveChat

Keywords

genetically modified mouse rat & cell models knockout knockin point mutation humanization inducible systems etc crispr cas9 homologous recombination rmce targeted transgenesis offtheshelf catalog mouse models immunology immunotherapy oncology immunooncology license preclinical models cancer research fundamental research clinical research freedom to operate biotechnology research humanized mice immunodeficient rodents knockout models cell lines crispr/cas9 biopharmaceutical research gene editing in vivo efficacy translational research pharmacokinetics biologics assessment target-specific models therapeutic antibodies human immune system glp-1r mouse model t-cell engagers custom mouse models scientific validation oncology models metabolism studies disease progression drug delivery systems gene function analysis validation data biomedical research syngeneic models human cd34+ cells complex tissue models rag1 knockout hla-a2 transgene tumor microenvironment immune checkpoints immunocompetent mice tissue engineering humanization technologies drug efficacy testing metabolic disease models autoimmunity models transgenic mice biomedical applications pharmacodynamic assessment research collaboration biotech innovations life science solutions model generation services predictive models forwards compatibility fda compliance hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans